TrialDiabetes, obesity & metabolism2026

Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg as an Add-On to Dose-Reduced Insulin Glargine versus Dose-Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE).

Helena W Rodbard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.